Christopher J. Hawkey

NIHR Nottingham Digestive Diseases Biomedical Research Unit — United Kingdom

Medicine · Health Sciences

62h-index20.7kcitations243works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory mediators and NSAID effects(106), Helicobacter pylori-related gastroenterology studies(87), Inflammatory Bowel Disease(35), Gastric Cancer Management and Outcomes(32), Antiplatelet Therapy and Cardiovascular Diseases(29)

Publications243 total

Optimizing mood prior to influenza vaccination in older adults: A three-arm randomized controlled trial.
Health Psychology·2023· 1 citedOpen Access
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
The Lancet·2022· 145 citedOpen Access
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease
Trials·2022· 24 citedOpen Access
Recruitment to a large scale randomised controlled clinical trial in primary care: the Helicobacter Eradication Aspirin Trial (HEAT)
Trials·2022· 4 citedOpen Access
Additional file 1 of Recruitment to a large scale randomised controlled clinical trial in primary care: the Helicobacter Eradication Aspirin Trial (HEAT)
Figshare·2022Open Access
<i>Helicobacter Pylori</i> Eradication for Primary Prevention of Upper Gastrointestinal Ulcer Bleeding in Older Patients Prescribed Aspirin (HEAT): A Randomised Placebo-Controlled Trial in Primary Care
SSRN Electronic Journal·2022· 1 citedOpen Access
Feasibility of conducting a randomized, placebo-controlled study assessing whether omega-3 fatty acids prevent gout flares when starting urate-lowering treatment
Rheumatology Advances in Practice·2022· 6 citedOpen Access
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
The Lancet·2020· 322 citedOpen Access
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial
The Lancet·2020· 369 citedOpen Access
Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial
Trials·2019· 25 citedOpen Access
Tranexamic acid for acute gastrointestinal bleeding (The HALT-IT trial): Statistical analysis plan for an international, randomised, double blind, placebo-controlled trial
2019Open Access
Tranexamic acid for acute gastrointestinal bleeding (The HALT-IT trial): Statistical analysis plan for an international, randomised, double blind, placebo-controlled trial
Research Square (Research Square)·2019· 3 citedOpen Access
Tranexamic acid for acute gastrointestinal bleeding (The HALT-IT trial): Statistical analysis plan for an international, randomised, double blind, placebo-controlled trial
2019Open Access
Tranexamic acid for acute gastrointestinal bleeding (The HALT-IT trial): Statistical analysis plan for an international, randomised, double blind, placebo-controlled trial
Research Square (Research Square)·2019· 1 citedOpen Access
Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitis
Digestive and Liver Disease·2018· 24 citedOpen Access
PWE-003 Acetarsol is an effective option in the management of refractory proctitis
2018Open Access
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial
˜The œLancet. Gastroenterology & hepatology·2017· 100 citedOpen Access
Resetting of the Mucosal T Cell Repertoire after Hematopoietic Stem Cell Transplantation in Refractory Crohn’s Disease
Gastroenterology·2017· 5 cited
OP004 Resetting of the mucosal T cell repertoire after hematopoietic stem cell transplantation in refractory Crohn's disease
Journal of Crohn s and Colitis·2017· 4 citedOpen Access
991 Prediction of Clinical and Endoscopic Remission After Autologous Stem Cell Transplantation in Treatment Refractory Crohn's Disease: Pooled Results From the ASTIC Trial
Gastroenterology·2016· 2 cited
page 1 of 13Next →

Frequent Co-authors

Loren Laine(5), Thomas J. Schnitzer(5), Claire Bombardier(4), Marc C. Hochberg(4), Yashwant R. Mahida(4), Krish Ragunath(4), Alise Reicin(3), A J Swannell(3), Neville D. Yeomans(3), Michael Doherty(3), Haleema Shakur‐Still(3), Vipul Jairath(3), Isla S. Mackenzie(3), Thomas M. MacDonald(3), Claudine G. Jennings(3), Paul Fortun(3), W. A. Stack(3), S Makh(3), John C. Atherton(3), Elizabeth Clark(3)